SPOK

Spok Holdings, Inc.

60
Fundamentals55/ 100
Valuation65/ 100
Upside potential45/ 100
Risk potential24/ 100

SPOK's fundamentals are mixed, but it looks cheap: trading at 13x earnings, below its usual 18x.

SPOK Fundamentals

MetricStatus
Stable
Healthy
Strong
Strong

SPOK's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.

SPOK PE Valuation

CHEAPFAIREXPENSIVE6.1x12x18x24x
CHEAPFAIREXPENSIVE6.1x12x18x24x
LevelPEPriceVs current
Cheap8.6x$7.56-35%
Current13x$11.62—
Fair18x$15.91+37%
Expensive22x$19.16+65%

Historical ranges are pointers, not guarantees.

SPOK's PE is in its cheap range at 13x.

SPOK Forward outlook

There aren't enough analyst estimates for SPOK to show an outlook.

SPOK Risk to reward

ScenarioChangePrice
Upside+20%$13.90
Downside-24%$8.78

Calculated from the latest close: $11.62 on Nov 12.

SPOK's one-year downside scenario is somewhat larger than its upside: −24% against +20%.

SPOK Earnings Per Share

Q4 2023: $0.77Q1 2024: $0.83Q2 2024: $0.77Q3 2024: $0.73Q4 2024: $0.73Q1 2025: $0.77Q2 2025: $0.82Q3 2025: $0.79Q4 2025: $0.75Q1 2026: $0.59Q2 2026: $0.57Q3 2026: $0.88
Q4 2023: $0.77Q1 2024: $0.83Q2 2024: $0.77Q3 2024: $0.73Q4 2024: $0.73Q1 2025: $0.77Q2 2025: $0.82Q3 2025: $0.79Q4 2025: $0.75Q1 2026: $0.59Q2 2026: $0.57Q3 2026: $0.88
QuarterTTM EPSYoY
Q3 2026$0.88+11%
Q2 2026$0.57-30%
Q1 2026$0.59-23%
Q4 2025$0.75+2.7%
Q3 2025$0.79+8.2%
Q2 2025$0.82+6.5%
Q1 2025$0.77-7.2%
Q4 2024$0.73-5.2%

SPOK's earnings per share have fallen from their peak: $0.88 over the past year, against $1.81 in late 2023.

SPOK Quarterly Revenue

Q4 2023: $34MQ1 2024: $35MQ2 2024: $34MQ3 2024: $35MQ4 2024: $34MQ1 2025: $36MQ2 2025: $36MQ3 2025: $34MQ4 2025: $34MQ1 2026: $33MQ2 2026: $35MQ3 2026: $33M
Q4 2023: $34MQ1 2024: $35MQ2 2024: $34MQ3 2024: $35MQ4 2024: $34MQ1 2025: $36MQ2 2025: $36MQ3 2025: $34MQ4 2025: $34MQ1 2026: $33MQ2 2026: $35MQ3 2026: $33M
QuarterRevenueYoY
Q3 2026$33M-2.6%
Q2 2026$35M-1.9%
Q1 2026$33.2M-8.5%
Q4 2025$33.9M-0.1%
Q3 2025$33.9M-2.9%
Q2 2025$35.7M+5%
Q1 2025$36.3M+4%
Q4 2024$33.9M-0.2%

SPOK's revenue fell from its 2019 peak and has held roughly level since: $33M last quarter, down 2.6% from the same quarter a year ago.

SPOK Free Cash Flow

Q4 2023: $11MQ1 2024: $1MQ2 2024: $7MQ3 2024: $10MQ4 2024: $8MQ1 2025: $2MQ2 2025: $6MQ3 2025: $8MQ4 2025: $10MQ1 2026: $2MQ2 2026: $6MQ3 2026: $12M
Q4 2023: $11MQ1 2024: $1MQ2 2024: $7MQ3 2024: $10MQ4 2024: $8MQ1 2025: $2MQ2 2025: $6MQ3 2025: $8MQ4 2025: $10MQ1 2026: $2MQ2 2026: $6MQ3 2026: $12M
QuarterFree cash flowYoY
Q3 2026$12.2M+62%
Q2 2026$5.9M-2%
Q1 2026$1.8M+22%
Q4 2025$10.1M+34%
Q3 2025$7.6M-26%
Q2 2025$6M-12%
Q1 2025$1.5M+34%
Q4 2024$7.5M-30%

SPOK generated $30M in free cash flow over the past year, up 33% from the year before.

SPOK Total Shares

Q4 2023: 20MQ1 2024: 20MQ2 2024: 20MQ3 2024: 21MQ4 2024: 21MQ1 2025: 21MQ2 2025: 21MQ3 2025: 21MQ4 2025: 21MQ1 2026: 21MQ2 2026: 21MQ3 2026: 21M
Q4 2023: 20MQ1 2024: 20MQ2 2024: 20MQ3 2024: 21MQ4 2024: 21MQ1 2025: 21MQ2 2025: 21MQ3 2025: 21MQ4 2025: 21MQ1 2026: 21MQ2 2026: 21MQ3 2026: 21M
PeriodChange %Net change
Quarterly+0.6%+128K shares
1 year+0.9%+184K shares
3 years+4.5%+909K shares
5 years+9%+1.7M shares
Available history+11%+2.1M shares

SPOK has 21M diluted shares, up 0.9% from a year ago.

SPOK Net Leverage

Q4 2023: -1.2xQ1 2024: -0.9xQ2 2024: -1.0xQ3 2024: -1.3xQ4 2024: -1.3xQ1 2025: -0.8xQ2 2025: -0.8xQ3 2025: -0.9xQ4 2025: -1.1xQ1 2026: -0.9xQ2 2026: -0.8xQ3 2026: -1.4x
Q4 2023: -1.2xQ1 2024: -0.9xQ2 2024: -1.0xQ3 2024: -1.3xQ4 2024: -1.3xQ1 2025: -0.8xQ2 2025: -0.8xQ3 2025: -0.9xQ4 2025: -1.1xQ1 2026: -0.9xQ2 2026: -0.8xQ3 2026: -1.4x
QuarterNet LeverageStatus
Q3 2026-1.4xNet Cash
Q2 2026-0.8xNet Cash
Q1 2026-0.9xNet Cash
Q4 2025-1.1xNet Cash
Q3 2025-0.9xNet Cash
Q2 2025-0.8xNet Cash
Q1 2025-0.8xNet Cash
Q4 2024-1.3xNet Cash

SPOK has more cash than debt.

SPOK Weekly Momentum

MetricValueStatus
RSI55.2Neutral
Stochastic76.0Neutral

SPOK's weekly RSI is 55 (neutral) and its Stochastic is 76 (neutral).

SPOK PE vs Healthcare Sector

MetricSPOKSector medianRelative
PE13x26x49% below
PE %27292 pts below

SPOK is trading at 13x earnings, a 49% discount to the Healthcare sector's median of 26x.

SPOK Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$11.05.3% above
20 week MA$10.87.3% above
50 week MA$11.50.9% above
100 week MA$13.917% below
200 week MA$14.117% below

SPOK has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 17% below its 200-week average.

SPOK Yearly ROI

YearStart priceEnd priceROI
2020$12.1$11.0-9%
2021$11.0$8.72-21%
2022$8.72$8.24-5.5%
2023$8.24$15.5+88%
2024$15.5$16.2+4.8%
2025$16.2$13.0-20%
2026 YTD$13.0$11.6-10%

SPOK has finished lower in four of the last six years. It's down 10% so far in 2026.

Give your agent the market.

Get API key